MX9802764A - Promotor homologo fuerte procedente de un hamster. - Google Patents
Promotor homologo fuerte procedente de un hamster.Info
- Publication number
- MX9802764A MX9802764A MX9802764A MX9802764A MX9802764A MX 9802764 A MX9802764 A MX 9802764A MX 9802764 A MX9802764 A MX 9802764A MX 9802764 A MX9802764 A MX 9802764A MX 9802764 A MX9802764 A MX 9802764A
- Authority
- MX
- Mexico
- Prior art keywords
- hamsters
- intensive
- promoter obtained
- homologous promoter
- promoter
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2830/00—Vector systems having a special element relevant for transcription
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2830/00—Vector systems having a special element relevant for transcription
- C12N2830/80—Vector systems having a special element relevant for transcription from vertebrates
- C12N2830/85—Vector systems having a special element relevant for transcription from vertebrates mammalian
Landscapes
- Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Zoology (AREA)
- Biotechnology (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- General Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Health & Medical Sciences (AREA)
- Wood Science & Technology (AREA)
- Biophysics (AREA)
- Biomedical Technology (AREA)
- Physics & Mathematics (AREA)
- Microbiology (AREA)
- Plant Pathology (AREA)
- Toxicology (AREA)
- Gastroenterology & Hepatology (AREA)
- Medicinal Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Saccharide Compounds (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
Abstract
El invento concierne a un promotor homologo fuerte procedente de un hámster. Especialmente, se trata en tal caso del promotor del gen, que codifica la proteína de fusion de ubiquitina-S27a. El promotor se puede utilizar para procedimientos destinados a la preparacion de productos génicos heterologos en células cultivadas, especialmente en células de CHO.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE19539493A DE19539493A1 (de) | 1995-10-24 | 1995-10-24 | Starker homologer Promotor aus Hamster |
Publications (1)
Publication Number | Publication Date |
---|---|
MX9802764A true MX9802764A (es) | 1998-11-30 |
Family
ID=7775593
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MX9802764A MX9802764A (es) | 1995-10-24 | 1998-04-07 | Promotor homologo fuerte procedente de un hamster. |
Country Status (11)
Country | Link |
---|---|
US (1) | US6063598A (es) |
EP (2) | EP1803815A3 (es) |
JP (2) | JP3966903B2 (es) |
AT (1) | ATE355370T1 (es) |
CA (1) | CA2234071C (es) |
DE (2) | DE19539493A1 (es) |
DK (1) | DK0857211T3 (es) |
ES (1) | ES2281905T3 (es) |
MX (1) | MX9802764A (es) |
PT (1) | PT857211E (es) |
WO (1) | WO1997015664A1 (es) |
Families Citing this family (76)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0961830A1 (en) * | 1997-01-29 | 1999-12-08 | Neurosearch A/S | EXPRESSION VECTORS AND METHODS FOR $i(IN VIVO) EXPRESSION OF THERAPEUTIC POLYPEPTIDES |
EP1319082B1 (en) * | 2000-09-18 | 2005-11-16 | Genzyme Corporation | Expression vectors containing hybrid ubiquitin promoters |
EP1624067A3 (en) * | 2000-09-18 | 2006-03-15 | Genzyme Corporation | Expression vectors containing hybrid ubiquitin promoters |
DE60236332D1 (de) * | 2001-07-04 | 2010-06-17 | Chromagenics Bv | DNS-Sequenzen mit anti-repressor Aktivität |
US7384744B2 (en) | 2002-11-29 | 2008-06-10 | Boehringer Ingelheim Pharma Gmbh & Co., Kg | Expression vector, methods for the production of heterologous gene products and for the selection of recombinant cells producing high levels of such products |
US7344886B2 (en) | 2002-11-29 | 2008-03-18 | Boehringer Ingelheim Pharma Gmbh & Co., Kg | Neomycin-phosphotransferase-genes and methods for the selection of recombinant cells producing high levels of a desired gene product |
DE10256083A1 (de) * | 2002-11-29 | 2004-08-12 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Expressionsvektor, Verfahren zur Herstellung von heterologen Genprodukten und Selektionsverfahren für hochproduzierende rekombinante Zellen |
US8669109B2 (en) | 2003-08-19 | 2014-03-11 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Methods of producing proteins in Chinese hamster ovary (CHO) cells |
DE10338531A1 (de) | 2003-08-19 | 2005-04-07 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Verfahren zur Reklonierung von Produktionszellen |
US20050101017A1 (en) * | 2003-11-10 | 2005-05-12 | Wojtek Auerbach | Method of improving gene targeting using a ubiquitin promoter |
GB0509965D0 (en) * | 2005-05-17 | 2005-06-22 | Ml Lab Plc | Improved expression elements |
US9163257B2 (en) * | 2005-06-20 | 2015-10-20 | Cadila Healthcare Limited | Expression vector and methods of producing high levels of proteins |
EP1806365A1 (en) | 2006-01-05 | 2007-07-11 | Boehringer Ingelheim International GmbH | Antibody molecules specific for fibroblast activation protein and immunoconjugates containing them |
US20080124760A1 (en) * | 2006-07-26 | 2008-05-29 | Barbara Enenkel | Regulatory Nucleic Acid Elements |
PE20141568A1 (es) | 2011-10-28 | 2014-11-21 | Neotope Biosciences Ltd | Anticuerpos humanizados que reconocen la alfa-sinucleina |
SG11201404321YA (en) | 2012-01-27 | 2014-08-28 | Neotope Biosciences Ltd | Humanized antibodies that recognize alpha-synuclein |
UA118441C2 (uk) | 2012-10-08 | 2019-01-25 | Протена Біосаєнсиз Лімітед | Антитіло, що розпізнає альфа-синуклеїн |
WO2014102103A2 (en) | 2012-12-31 | 2014-07-03 | Boehringer Ingelheim International Gmbh | Heterologous intron within a signal peptide |
WO2014102101A1 (en) | 2012-12-31 | 2014-07-03 | Boehringer Ingelheim International Gmbh | Novel intron sequences |
CU24446B1 (es) | 2013-03-13 | 2019-10-04 | Prothena Biosciences Ltd | Un anticuerpo monoclonal humanizado que se une a tau |
WO2014182972A2 (en) | 2013-05-10 | 2014-11-13 | The Regents Of The University Of California | Diagnostic and monitoring system for huntington's disease |
US10513555B2 (en) | 2013-07-04 | 2019-12-24 | Prothena Biosciences Limited | Antibody formulations and methods |
US9850302B2 (en) | 2013-07-12 | 2017-12-26 | Prothena Biosciences Limited | Antibodies that recognize IAPP |
WO2015004633A1 (en) | 2013-07-12 | 2015-01-15 | Neotope Biosciences Limited | Antibodies that recognize islet-amyloid polypeptide (iapp) |
EP3071974A2 (en) | 2013-11-19 | 2016-09-28 | Prothena Biosciences Limited | Monitoring immunotherapy of lewy body disease from constipation symptoms |
CA2935724C (en) * | 2013-12-31 | 2023-06-20 | R1 B3 Holding B.V. | Construct and sequence for enhanced gene expression |
TW201623331A (zh) | 2014-03-12 | 2016-07-01 | 普羅帝納生物科學公司 | 抗黑色素瘤細胞黏著分子(mcam)抗體類及使用彼等之相關方法 |
WO2015136472A1 (en) | 2014-03-12 | 2015-09-17 | Prothena Biosciences Limited | Anti-laminin4 antibodies specific for lg4-5 |
KR20160131082A (ko) | 2014-03-12 | 2016-11-15 | 프로테나 바이오사이언시즈 리미티드 | Lg1-3에 특이적인 항-라미닌4 항체 |
KR20160127825A (ko) | 2014-03-12 | 2016-11-04 | 프로테나 바이오사이언시즈 리미티드 | 항-mcam 항체 및 관련된 사용 방법 |
WO2015155694A1 (en) | 2014-04-08 | 2015-10-15 | Prothena Biosciences Limited | Blood-brain barrier shuttles containing antibodies recognizing alpha-synuclein |
RU2021103436A (ru) | 2014-12-10 | 2021-02-25 | Опко Байолоджикс Лтд. | Способы производства ctp-модифицированных полипептидов гормона роста длительного действия |
TWI786505B (zh) | 2015-01-28 | 2022-12-11 | 愛爾蘭商普羅佘納生物科技有限公司 | 抗甲狀腺素運送蛋白抗體 |
TWI711631B (zh) | 2015-01-28 | 2020-12-01 | 愛爾蘭商普羅佘納生物科技有限公司 | 抗甲狀腺素運送蛋白抗體 |
TWI781507B (zh) | 2015-01-28 | 2022-10-21 | 愛爾蘭商普羅佘納生物科技有限公司 | 抗甲狀腺素運送蛋白抗體 |
JP6983073B2 (ja) | 2015-05-18 | 2021-12-17 | ザイムトロニクス インコーポレイテッド | 磁気固定化殺菌性酵素 |
US10792649B2 (en) | 2015-07-15 | 2020-10-06 | Zymtronix, Llc | Automated bionanocatalyst production |
WO2017046774A2 (en) | 2015-09-16 | 2017-03-23 | Prothena Biosciences Limited | Use of anti-mcam antibodies for treatment or prophylaxis of giant cell arteritis, polymyalgia rheumatica or takayasu's arteritis |
JP2018530540A (ja) | 2015-09-16 | 2018-10-18 | プロセナ バイオサイエンシーズ リミテッド | 巨細胞動脈炎、リウマチ性多発筋痛症又は高安動脈炎の処置又は予防のための抗mcam抗体の使用 |
WO2017149513A1 (en) | 2016-03-03 | 2017-09-08 | Prothena Biosciences Limited | Anti-mcam antibodies and associated methods of use |
WO2017153955A1 (en) | 2016-03-09 | 2017-09-14 | Prothena Biosciences Limited | Use of anti-mcam antibodies for treatment or prophylaxis of granulomatous lung diseases |
WO2017153953A1 (en) | 2016-03-09 | 2017-09-14 | Prothena Biosciences Limited | Use of anti-mcam antibodies for treatment or prophylaxis of granulomatous lung diseases |
CA3022765A1 (en) | 2016-05-02 | 2017-11-09 | Prothena Biosciences Limited | Antibodies recognizing tau |
EP3452508A1 (en) | 2016-05-02 | 2019-03-13 | Prothena Biosciences Limited | Antibodies recognizing tau |
CN109415432B (zh) | 2016-05-02 | 2022-07-08 | 普罗塞纳生物科学有限公司 | Tau免疫疗法 |
WO2017208210A1 (en) | 2016-06-03 | 2017-12-07 | Prothena Biosciences Limited | Anti-mcam antibodies and associated methods of use |
WO2018007922A2 (en) | 2016-07-02 | 2018-01-11 | Prothena Biosciences Limited | Anti-transthyretin antibodies |
WO2018007924A2 (en) | 2016-07-02 | 2018-01-11 | Prothena Biosciences Limited | Anti-transthyretin antibodies |
JP7016470B2 (ja) | 2016-07-02 | 2022-02-07 | プロセナ バイオサイエンシーズ リミテッド | 抗トランスサイレチン抗体 |
KR20240006077A (ko) | 2016-07-11 | 2024-01-12 | 옵코 바이오로직스 리미티드 | 지속성 응고 인자 vii 및 그 제조 방법 |
CN109788762B (zh) | 2016-08-13 | 2023-07-11 | 齐姆特罗尼克斯催化系统股份有限公司 | 磁性固定化的杀生物酶和杀生物化学品 |
EA201991692A1 (ru) | 2017-01-13 | 2019-12-30 | Дзе Риджентс Оф Дзе Юниверсити Оф Калифорния | Иммуносконструированные плюрипотентные клетки |
KR20200030029A (ko) | 2017-05-02 | 2020-03-19 | 프로테나 바이오사이언시즈 리미티드 | 타우 인식 항체 |
AU2017434556A1 (en) | 2017-09-28 | 2020-04-09 | F. Hoffmann-La Roche Ag | Dosing regimes for treatment of synucleinopathies |
EP3846938A4 (en) | 2018-09-05 | 2022-06-01 | ZYMtronix Catalytic Systems, Inc. | IMMOBILIZED ENZYMES AND MICROSOOMES ON MAGNETIC FRAMEWORKS |
KR20210094610A (ko) | 2018-11-26 | 2021-07-29 | 포티 세븐, 인코포레이티드 | c-Kit에 대한 인간화 항체 |
PE20212324A1 (es) | 2019-03-03 | 2021-12-14 | Prothena Biosciences Ltd | Anticuerpos que reconocen tau |
US11162079B2 (en) | 2019-05-10 | 2021-11-02 | The Regents Of The University Of California | Blood type O Rh-hypo-immunogenic pluripotent cells |
CA3144621A1 (en) | 2019-06-26 | 2020-12-30 | The Regents Of The University Of California | Sirpalpha-silenced natural killer (nk) cells |
JP2022543112A (ja) | 2019-08-01 | 2022-10-07 | サナ バイオテクノロジー,インコーポレイテッド | Dux4発現細胞およびそれらの使用 |
WO2021041316A1 (en) | 2019-08-23 | 2021-03-04 | Sana Biotechnology, Inc. | Cd24 expressing cells and uses thereof |
JP2023510872A (ja) | 2020-01-13 | 2023-03-15 | サナ バイオテクノロジー,インコーポレイテッド | 血液型抗原の修飾 |
MX2022008783A (es) | 2020-01-17 | 2022-12-13 | Sana Biotechnology Inc | Cambios de seguridad para la regulación de la expresión génica. |
TW202202155A (zh) | 2020-03-25 | 2022-01-16 | 美商薩那生物科技公司 | 用於治療神經病症及病況之低免疫原性神經細胞 |
EP4196568A1 (en) | 2020-08-13 | 2023-06-21 | Sana Biotechnology, Inc. | Methods of treating sensitized patients with hypoimmunogenic cells, and associated methods and compositions |
KR20230137900A (ko) | 2020-12-31 | 2023-10-05 | 사나 바이오테크놀로지, 인크. | Car-t 활성을 조정하기 위한 방법 및 조성물 |
EP4340851A1 (en) | 2021-05-19 | 2024-03-27 | Sana Biotechnology, Inc. | Hypoimmunogenic rhd negative primary t cells |
EP4347797A1 (en) | 2021-05-27 | 2024-04-10 | Sana Biotechnology, Inc. | Hypoimmunogenic cells comprising engineered hla-e or hla-g |
EP4370544A2 (en) | 2021-07-14 | 2024-05-22 | Sana Biotechnology, Inc. | Altered expression of y chromosome-linked antigens in hypoimmunogenic cells |
AU2022326565A1 (en) | 2021-08-11 | 2024-02-08 | Sana Biotechnology, Inc. | Genetically modified cells for allogeneic cell therapy |
IL310691A (en) | 2021-08-11 | 2024-04-01 | Sana Biotechnology Inc | Genetically modified primary cells for allogeneic cell therapy |
WO2023019225A2 (en) | 2021-08-11 | 2023-02-16 | Sana Biotechnology, Inc. | Genetically modified cells for allogeneic cell therapy to reduce instant blood mediated inflammatory reactions |
AU2022325231A1 (en) | 2021-08-11 | 2024-02-08 | Sana Biotechnology, Inc. | Genetically modified cells for allogeneic cell therapy to reduce complement-mediated inflammatory reactions |
WO2023158836A1 (en) | 2022-02-17 | 2023-08-24 | Sana Biotechnology, Inc. | Engineered cd47 proteins and uses thereof |
WO2023173123A1 (en) | 2022-03-11 | 2023-09-14 | Sana Biotechnology, Inc. | Genetically modified cells and compositions and uses thereof |
WO2023183313A1 (en) | 2022-03-22 | 2023-09-28 | Sana Biotechnology, Inc. | Engineering cells with a transgene in b2m or ciita locus and associated compositions and methods |
-
1995
- 1995-10-24 DE DE19539493A patent/DE19539493A1/de not_active Ceased
-
1996
- 1996-10-24 DK DK96937224T patent/DK0857211T3/da active
- 1996-10-24 JP JP51628897A patent/JP3966903B2/ja not_active Expired - Lifetime
- 1996-10-24 EP EP06126019A patent/EP1803815A3/de not_active Withdrawn
- 1996-10-24 WO PCT/EP1996/004631 patent/WO1997015664A1/de active IP Right Grant
- 1996-10-24 AT AT96937224T patent/ATE355370T1/de active
- 1996-10-24 EP EP96937224A patent/EP0857211B1/de not_active Expired - Lifetime
- 1996-10-24 PT PT96937224T patent/PT857211E/pt unknown
- 1996-10-24 ES ES96937224T patent/ES2281905T3/es not_active Expired - Lifetime
- 1996-10-24 US US09/051,969 patent/US6063598A/en not_active Expired - Lifetime
- 1996-10-24 DE DE59611420T patent/DE59611420D1/de not_active Expired - Lifetime
- 1996-10-24 CA CA002234071A patent/CA2234071C/en not_active Expired - Lifetime
-
1998
- 1998-04-07 MX MX9802764A patent/MX9802764A/es active IP Right Grant
-
2006
- 2006-07-07 JP JP2006187719A patent/JP2006320330A/ja active Pending
Also Published As
Publication number | Publication date |
---|---|
EP0857211B1 (de) | 2007-02-28 |
ATE355370T1 (de) | 2006-03-15 |
JP3966903B2 (ja) | 2007-08-29 |
DE59611420D1 (de) | 2007-04-12 |
WO1997015664A1 (de) | 1997-05-01 |
DE19539493A1 (de) | 1997-04-30 |
EP0857211A1 (de) | 1998-08-12 |
PT857211E (pt) | 2007-03-30 |
ES2281905T3 (es) | 2007-10-01 |
CA2234071A1 (en) | 1997-05-01 |
CA2234071C (en) | 2003-01-21 |
US6063598A (en) | 2000-05-16 |
EP1803815A3 (de) | 2007-08-29 |
JPH11513572A (ja) | 1999-11-24 |
EP1803815A2 (de) | 2007-07-04 |
DK0857211T3 (da) | 2007-03-26 |
JP2006320330A (ja) | 2006-11-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MX9802764A (es) | Promotor homologo fuerte procedente de un hamster. | |
DK0770139T3 (da) | En svamp, hvor areA-genet er blevet modificeret, samt et areA-gen fra aspergillus oryzae | |
AU6724194A (en) | Nucleotide sequences for the control of the expression of dna sequences in a cellular host | |
PL332431A1 (en) | High protein expression level | |
EP1020528A3 (en) | Method for producing secreted proteins | |
PL341760A1 (en) | Expression cloning in mildew fungi | |
ZA935915B (en) | Modified fungal cells and method for producing recombinant products | |
PL345408A1 (en) | Overexpression of phytase genes in yeast systems | |
AU1383695A (en) | An enzyme feed additive and animal feed including it | |
WO1994018316A3 (en) | Apolipoprotein b mrna editing protein compositions and methods | |
IL143670A0 (en) | Methods for the expression of active protein-immunoglobulin fusions, active protein-immunoglobulin fusions obtained thereby and pharmaceutical compositions containing the same | |
ATE323770T1 (de) | Polypeptide mit lysophospholipaseaktivität und nukleinesäuren die sie kodieren | |
HU9502608D0 (en) | Process for production of protein | |
NZ310710A (en) | Fermentative production of hydrophobic proteins such as ifn-<beta> | |
IL135983A0 (en) | Adenovirus vectors and method for reducing homologous recombination phenomena | |
IL88151A (en) | Interleukin-7 protein, dna sequences encoding it, its preparation and compositions containing it | |
AU3802595A (en) | Tripeptidyl aminopeptidase | |
AU6724794A (en) | GRB3-3 gene, its variants and their uses | |
ES8205432A1 (es) | Un metodo de determinar la cantidad de un polipeptido enca- riotico o procariotico producido por un microorganismo | |
EP0776972A4 (en) | GENE ENCODING THE IgG-Fc-BINDING PROTEIN | |
AU1720397A (en) | Recombinant expression of s-layer proteins | |
AU5727099A (en) | A 2,6-beta-d-fructan hydrolase enzyme and processes for using the enzyme | |
EP1010761A4 (en) | UNCOMFORTABLE | |
GB9726897D0 (en) | Process | |
AU8493198A (en) | Increasing production of proteins in gram-positive microorganisms |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FG | Grant or registration |